Role of TNF-alpha during central sensitization in preclinical studies

Pablo Andrade*, Veerle Visser-Vandewalle, Carolin Hoffmann, Harry W. M. Steinbusch, M.A.R.C. Daemen, Govert Hoogland

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

46 Citations (Web of Science)


Tumor necrosis factor-alpha (TNF-alpha) is a principal mediator in pro-inflammatory processes that involve necrosis, apoptosis and proliferation. Experimental and clinical evidence demonstrate that peripheral nerve injury results in activation and morphological changes of microglial cells in the spinal cord. These adjustments occur in order to initiate an inflammatory cascade in response to the damage. Between the agents involved in this reaction, TNF-alpha is recognized as a key player in this process as it not only modulates lesion formation, but also because it is suggested to induce nociceptive signals. Nowadays, even though the function of TNF-alpha in inflammation and pain production seems to be generally accepted, diverse sources of literature point to different pathways and outcomes. In this review, we systematically searched and reviewed original articles from the past 10 years on animal models of peripheral nervous injury describing TNF-alpha expression in neural tissue and pain behavior.
Original languageEnglish
Pages (from-to)757-771
JournalNeurological Sciences
Issue number5
Publication statusPublished - Oct 2011


  • TNF-alpha
  • Central sensitization
  • Neuropathic pain
  • Preclinical studies
  • Neuroinflammation

Cite this